The ICH E9(R1) Estimand Framework in the Context of Real-World Data and Observational Studies

被引：0

作者：

Husemoen, Lotte ^{[1
]}

Morga, Antonia ^{[2
]}

Remiro-Azocar, Antonio ^{[3
]}

Kleinjung, Frank ^{[4
]}

Rantell, Khadija Rerhou ^{[5
]}

Besseghir, Amel ^{[6
]}

Rosettani, Barbara ^{[7
]}

Allignol, Arthur ^{[8
]}

Vaitsiakhovich, Tatsiana ^{[9
]}

Polavieja, Pepa ^{[1
]}

机构：

[1] Novo Nordisk, Bagsvaerd, Denmark

[2] Astellas Pharma Europe Ltd, Addlestone, Surrey, England

[3] Bayer, Leverkusen, Germany

[4] Bayer AG, Leverkusen, Germany

[5] MHRA, London, England

[6] SwissBiosim, Biosimilars, Biopharmaceut, Eysins, Switzerland

[7] Bristol Myers Squibb, New York, NY USA

[8] Daiichi Sankyo Europe GmbH, Munich, Germany

[9] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

1229

引用

页码：553 / 554

页数：2

共 50 条

[21] Framework for approaching federated causal inference based on real-world observational data sources
Meurisse, M.
Schutte, N.
Van Goethem, N.
Estupinan-Romero, F.
Bernal-Delgado, E.
EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
[22] A METHODOLOGICAL FRAMEWORK TO CONDUCT DATA SOURCES LANDSCAPING FOR REAL-WORLD STUDIES (RWS)
Dong, Z.
Chen, S. H.
Taurel, A. F.
Toh, K. C.
Kleinman, N. J.
VALUE IN HEALTH, 2023, 26 (06) : S292 - S292
[23] ICH E14 Q & A (R1) document: perspectives on the updated recommendations on thorough QT studies
Shah, Rashmi R.
Morganroth, Joel
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (04) : 959 - 965
[24] USING REAL-WORLD DATA TO INFORM SMARTER CLINICAL TRIALS AND PROSPECTIVE OBSERVATIONAL STUDIES
Mehta, S.
Mountford, W. K.
McDonald, M. R.
Stolper, R.
Zakar, J.
Lobeck, F.
Christian, J. B.
Lang, K.
VALUE IN HEALTH, 2017, 20 (05) : A345 - A345
[25] Framework for federated causal inference based on real-world observational data sources (BY-COVID)
Meurisse, M.
Estupinan-Romero, F.
Van Goethem, N.
Gonzalez-Galindo, J.
Bernal-Delgado, E.
EUROPEAN JOURNAL OF PUBLIC HEALTH, 2023, 33
[26] The Certainty Framework for Assessing Real-World Data in Studies of Medical Product Safety and Effectiveness
Cocoros, Noelle M.
Arlett, Peter
Dreyer, Nancy A.
Ishiguro, Chieko
Iyasu, Solomon
Sturkenboom, Miriam
Zhou, Wei
Toh, Sengwee
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (05) : 1189 - 1196
[27] Characterization of real-world data sources to support observational studies of biologics, including biosimilars in oncology
Seals, Ryan M.
Lockhart, Catherine
Lin, Nancy
Seeger, John D.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 164 - 165
[28] Investigating the Provision and Context of Use of Hearing Aid Listening Programs From Real-world Data: Observational Study
Pasta, Alessandro
Szatmari, Tiberiu-Ioan
Christensen, Jeppe Hoy
Jensen, Kasper Juul
Pontoppidan, Niels Henrik
Sun, Kang
Larsen, Jakob Eg
JOURNAL OF MEDICAL INTERNET RESEARCH, 2022, 24 (10)
[29] A Framework for Extension Studies Using Real-World Data to Examine Long-Term Safety and Effectiveness
Mehmet Burcu
Cyntia B. Manzano-Salgado
Anne M. Butler
Jennifer B. Christian
Therapeutic Innovation & Regulatory Science, 2022, 56 : 15 - 22
[30] A Framework for Methodological Choice and Evidence Assessment for Studies Using External Comparators from Real-World Data
Gray, Christen M.
Grimson, Fiona
Layton, Deborah
Pocock, Stuart
Kim, Joseph
DRUG SAFETY, 2020, 43 (07) : 623 - 633

← 1 2 3 4 5 →